Literature DB >> 18941847

Changes in quality of life after balloon treatment followed by gastric banding in severely obese patients--the use of two different quality of life questionnaires.

Sonja J E Rutten1, Suzan de Goederen-van der Meij, Robert G J M Pierik, Elisabeth M H Mathus-Vliegen.   

Abstract

BACKGROUND: Improvements in quality of life (QOL) obtained by weight loss have mainly been reported after bariatric surgery. QOL has not been investigated in surgical patients first losing weight by nonsurgical means followed by a surgical intervention and never simultaneously by two QOL-a generic and a disease-specific-questionnaires.
METHODS: Prospective data were obtained from 40 consecutive patients (mean age 36.6 years, body weight 142.4 kg, body mass index (BMI) 46.5 kg/m2). Two different QOL questionnaires, the generic Medical Outcomes Study Short Form-36 (SF-36) and the disease-specific Health-Related Quality of Life (HRQL) questionnaire, were evaluated at three points in time: at the start, 3 months after the placement of an intragastric balloon that remained in situ for 6 months, and 3 months after subsequent gastric banding.
RESULTS: QOL scores revealed a significant improvement in many health domains, with an earlier improvement with the disease-specific HRQL, whereas the generic QOL questionnaire lagged behind. However, in the end, the SF-36 caught up completely to normal-weight levels, whereas some scales of the HRQL remained below these levels. Work productivity and involvement in sports improved significantly. BMI declined significantly over time, but no correlation with SF-36 and HRQL score changes was found.
CONCLUSION: The QOL improved substantially independent of changes in BMI. Because of the divergent outcomes of generic and disease-specific QOL questionnaires, prospective studies should examine the sensitivity to changes of both kinds of QOL questionnaires.

Entities:  

Mesh:

Year:  2008        PMID: 18941847     DOI: 10.1007/s11695-008-9732-3

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  40 in total

1.  Quality of life assessment in the morbidly obese.

Authors:  Ninh Nguyen; Estaban J Varela; Tien Nguyen; Samuel E Wilson
Journal:  Obes Surg       Date:  2006-05       Impact factor: 4.129

2.  Translation, validation, and norming of the Dutch language version of the SF-36 Health Survey in community and chronic disease populations.

Authors:  N K Aaronson; M Muller; P D Cohen; M L Essink-Bot; M Fekkes; R Sanderman; M A Sprangers; A te Velde; E Verrips
Journal:  J Clin Epidemiol       Date:  1998-11       Impact factor: 6.437

Review 3.  [Overweight. II. Determinants of overweight and strategies for prevention].

Authors:  E M Mathus-Vliegen
Journal:  Ned Tijdschr Geneeskd       Date:  1998-09-05

4.  Quality of life assessment of morbidly obese patients: effect of weight-reducing surgery.

Authors:  W G van Gemert; E M Adang; J W Greve; P B Soeters
Journal:  Am J Clin Nutr       Date:  1998-02       Impact factor: 7.045

5.  Quality of life following laparoscopic gastric banding in patients with morbid obesity.

Authors:  S M Freys; H Tigges; J Heimbucher; K H Fuchs; M Fein; A Thiede
Journal:  J Gastrointest Surg       Date:  2001 Jul-Aug       Impact factor: 3.452

6.  Six months of balloon treatment does not predict the success of gastric banding.

Authors:  Suzan de Goederen-van der Meij; Robert G J M Pierik; Marco Oudkerk Pool; Dirk J Gouma; Lisbeth M Mathus-Vliegen
Journal:  Obes Surg       Date:  2007-01       Impact factor: 4.129

Review 7.  Does obesity surgery improve psychosocial functioning? A systematic review.

Authors:  S Herpertz; R Kielmann; A M Wolf; M Langkafel; W Senf; J Hebebrand
Journal:  Int J Obes Relat Metab Disord       Date:  2003-11

Review 8.  Measuring health-related quality of life.

Authors:  G H Guyatt; D H Feeny; D L Patrick
Journal:  Ann Intern Med       Date:  1993-04-15       Impact factor: 25.391

Review 9.  Changes in comorbidities and improvements in quality of life after LAP-BAND placement.

Authors:  John B Dixon; Paul E O'Brien
Journal:  Am J Surg       Date:  2002-12       Impact factor: 2.565

10.  Pre- and postoperative psychological characteristics in morbidly obese patients.

Authors:  G M Papageorgiou; A Papakonstantinou; E Mamplekou; I Terzis; J Melissas
Journal:  Obes Surg       Date:  2002-08       Impact factor: 4.129

View more
  5 in total

1.  Intragastric Balloon Device: Weight Loss and Satisfaction Degree.

Authors:  Silvia Palmisano; Marta Silvestri; Barbara Melchioretto; Michela Giuricin; Fabiola Giudici; Alessandra Lucchetta; Vittoria Pia Barbieri; Edoardo Osenda; Flavia Urban; Catrin Simeth; Fabio Monica; Nicolò de Manzini
Journal:  Obes Surg       Date:  2016-09       Impact factor: 4.129

2.  Validation of the Greek translation of the obesity-specific Moorehead-Ardelt Quality-of-Life Questionnaire II.

Authors:  Vasileios Charalampakis; Markos Daskalakis; Georgios Bertsias; John A Papadakis; John Melissas
Journal:  Obes Surg       Date:  2012-05       Impact factor: 4.129

Review 3.  Assessment tools in obesity - psychological measures, diet, activity, and body composition.

Authors:  Laura Beechy; Jennie Galpern; Andrew Petrone; Sai Krupa Das
Journal:  Physiol Behav       Date:  2012-04-24

4.  Psychological Aspects of Treatment with Intragastric Balloon for Management of Obesity: A Systematic Review of the Literature.

Authors:  Giada Pietrabissa; Vanessa Bertuzzi; Susan Simpson; Anna Guerrini Usubini; Roberto Cattivelli; Simona Bertoli; Enrico Mozzi; Giancarlo Roviaro; Gianluca Castelnuovo; Enrico Molinari
Journal:  Obes Facts       Date:  2021-11-23       Impact factor: 3.942

5.  Impact of 6 months of treatment with intragastric balloon on body fat and quality of life in obese individuals with metabolic syndrome.

Authors:  Erika Paniago Guedes; Eduardo Madeira; Thiago Thomaz Mafort; Miguel Madeira; Rodrigo Oliveira Moreira; Laura Maria Carvalho de Mendonça; Amélio Fernando de Godoy-Matos; Agnaldo José Lopes; Maria Lucia Fleiuss Farias
Journal:  Health Qual Life Outcomes       Date:  2017-10-24       Impact factor: 3.186

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.